» Authors » Grace H Tabada

Grace H Tabada

Explore the profile of Grace H Tabada including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 256
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fang M, Reynolds K, Tabada G, Prasad P, Sung S, Parks A, et al.
JAMA Netw Open . 2023 Mar; 6(3):e232338. PMID: 36912838
Importance: Patients hospitalized with COVID-19 have higher rates of venous thromboembolism (VTE), but the risk and predictors of VTE among individuals with less severe COVID-19 managed in outpatient settings are...
2.
Go A, Reynolds K, Tabada G, Prasad P, Sung S, Garcia E, et al.
Chest . 2021 Jul; 160(4):1459-1470. PMID: 34293316
Background: Limited existing data suggest that the novel COVID-19 may increase risk of VTE, but information from large, ethnically diverse populations with appropriate control participants is lacking. Research Question: Does...
3.
Shen E, Lee J, Mularski R, Crawford P, Go A, Sung S, et al.
Chest . 2021 Jan; 159(6):2233-2243. PMID: 33482176
Background: Multiple morbidity is the norm in advanced COPD and contributes to high symptom burden and worse outcomes. Research Question: Can distinct comorbidity profiles be identified and validated in a...
4.
Ambrosy A, Fitzpatrick J, Tabada G, Gurwitz J, Artz A, Schrier S, et al.
Int J Cardiol . 2020 Mar; 309:95-99. PMID: 32201101
Background: Low transferrin saturation (TSAT) or reduced serum ferritin level are suggestive of iron deficiency but the relationship between iron parameters and outcomes has not been systematically evaluated in older...
5.
Budayr A, Tan T, Lo J, Zaroff J, Tabada G, Yang J, et al.
BMC Endocr Disord . 2020 Feb; 20(1):25. PMID: 32075620
Background: Whether lower dose cabergoline therapy for hyperprolactinemia increases risk of valvular dysfunction remains controversial. We examined valvular abnormalities among asymptomatic adults with hyperprolactinemia treated with dopamine agonists. Methods: This...
6.
Freeman J, Tabada G, Reynolds K, Sung S, Singer D, Wang P, et al.
Am J Cardiol . 2019 Dec; 125(4):553-561. PMID: 31843233
The impact of atrial fibrillation (AF) catheter ablation versus chronic antiarrhythmic therapy alone on clinical outcomes such as death and stroke remains unclear. We compared adverse outcomes for AF ablation...
7.
Ambrosy A, Gurwitz J, Tabada G, Artz A, Schrier S, Rao S, et al.
Eur Heart J Qual Care Clin Outcomes . 2019 Mar; 5(4):361-369. PMID: 30847487
Aims: Limited data exist on the epidemiology, evaluation, and prognosis of otherwise unexplained anaemia of the elderly in heart failure (HF). Thus, we aimed to determine the incidence of anaemia,...
8.
Bansal N, Szpiro A, Reynolds K, Smith D, Magid D, Gurwitz J, et al.
JAMA Intern Med . 2018 Feb; 178(3):390-398. PMID: 29404570
Importance: Chronic kidney disease (CKD) is common in adults with heart failure and is associated with an increased risk of sudden cardiac death. Randomized trials of participants without CKD have...
9.
Freeman J, Tabada G, Reynolds K, Sung S, Liu T, Gupta N, et al.
Am J Cardiol . 2018 Jan; 121(5):602-608. PMID: 29331355
Contemporary data on complications and resource utilization after atrial fibrillation (AF) ablation are limited. We evaluated rates and risk factors for procedural complication, rehospitalization, and emergency department visits after AF...
10.
Sax D, Mark D, Hsia R, Tan T, Tabada G, Go A
Circ Heart Fail . 2017 Dec; 10(12). PMID: 29237710
Background: Although 80% of patients with heart failure seen in the emergency department (ED) are admitted, less is known about short-term outcomes and demand for services among discharged patients. Methods...